New Diabetes Drugs a Boon for Patients with Heart Failure

By
estaff
-
Published:
0
SGLT2 inhibitors not only lower blood sugar, but reduce the risk of death, which is elevated in people with type 2 diabetes. © juststock | Getty Images
SGLT2 inhibitors go above and beyond lowering blood sugar to prevent heart failure-related deaths and hospitalizations. By Holly Strawbridge Patients with diabetes have numerous options for drugs to lower their blood sugar (glucose) levels. But a newer class of diabetes medications known as sodium glucose cotransporter 2 (SGLT2) inhibitors has benefits that far surpass those […]
To continue reading this article or issue you must be a paid subscriber. Sign in
Subscribe

Subscribe to Heart Advisor

Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access

RELATED ARTICLESMORE FROM AUTHOR